Pfizer Break Ground On New Andover Facility

ANDOVER – Pfizer broke ground on a $200 million project Thursday at its Andover campus.

The projects calls for the addition of a 170,000-square-foot biologics clinical manufacturing facility.

The 5-story building is expected to be operational by January 2019. The facility will house 75 new employees who will produce vaccines and biologics, according to a press release.

“The expansion of Pfizer’s presence in Andover will provide state-of-the-art manufacturing to help bring new medicines and vaccines to the patients we serve,” Pfizer SVP of research and development’s BioTheraputics pharmaceutical sciences unit John Ludwig said in the release. “Andover is a crucial part of our global footprint for both clinical and commercial manufacturing, and we believe it provides an attractive location for growth in the coming years.”

Pfizer's facility currently is home to seven buildings and employs 1,200. The project is expected to create 200 construction jobs.

Image via Pfizer